美国类风湿关节炎达标治疗实施现状:随机对照试验基线数据分析
本研究基于一项随机对照试验的基线数据,纳入美国11个中心46名医生的641例类风湿关节炎患者,评估达标治疗(TTT)实施情况。结果显示TTT实施不理想:64.3%的访视无任何TTT组分,仅0.3%的访视包含全部组分;实施情况在不同医生和中心间差异显著,且风湿科医生经验更丰富与更高的实施评分相关。
要点
- 美国风湿科实践中TTT实施率低,64.3%访视无任何TTT组分。
- TTT实施在不同医生和中心间存在显著差异(P<0.0001)。
- 风湿科医生经验>20年者比专科培训医师更可能记录更多TTT组分(OR 7.68)。
核心结论
- 在美国风湿科实践中,类风湿关节炎达标治疗策略的依从性不理想,且在不同医生和中心间存在差异。
研究设计与样本
- 基于随机对照试验TTT-in-RA的基线数据,纳入美国11个中心46名医生的641例患者,评估TTT的4个核心特征并计算实施评分。
主要发现
- 64.3%的访视无任何TTT组分,33.1%有1个组分,2.3%有2个组分,0.3%有全部组分。
- TTT实施在不同医生和中心间差异显著(P<0.0001)。
- 多变量模型中,风湿科医生经验更丰富与更高实施评分相关(趋势P=0.01)。
- 与专科培训医师相比,执业经验>20年的医生更可能记录更多TTT组分(OR 7.68,95%CI 1.46-40.52)。
临床怎么用
- 临床实践中应系统记录疾病目标、疾病活动度指标、共享决策,并在未达标时调整治疗,以提高TTT依从性。
局限性
- 本研究为基线横断面分析,仅反映美国参与试验的中心情况,不能推断因果关系或推广至所有风湿科实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: A treat-to-target (TTT) strategy is recommended in rheumatoid arthritis (RA). However, health care providers' adherence to TTT in clinical practice remains unclear. We examined adherence to TTT in RA at US rheumatology sites. METHODS: We used baseline information from the randomized controlled Treat-to-Target in RA: Collaboration to Improve Adoption and Adherence trial, which recruited 641 patients from 46 providers practicing at 11 US sites. We obtained data on the implementation of TTT, patient covariates, provider characteristics, and site variables. We examined the implementation of TTT using 4 cardinal features: recording a disease target, recording a disease activity measure, engaging in shared decision-making, and changing treatment if not at disease target. These features were assessed across sites and providers. We calculated a TTT implementation score as the percentage of features noted. We examined the association between patient, provider, and site covariates and TTT implementation score using proportional odds models. RESULTS: The implementation of TTT at baseline was suboptimal: 64.3% of visits had none of the TTT components present, 33.1% had 1 component, 2.3% had 2 components, and 0.3% had all components. The implementation of TTT was significantly different across providers and sites (P < 0.0001 for all). In the multivariable model, we observed that more experience as a rheumatologist was associated with a higher implementation score (P = 0.01 for trend). Compared with fellows, providers with >20 years of experience in practice were more likely to have more TTT components recorded (odds ratio 7.68 [95% confidence interval 1.46-40.52]). CONCLUSION: We found that adherence to a TTT strategy in RA was suboptimal, and it differed across providers and sites.
引用
- Yu Z, Lu B, Agosti J, et al. Implementation of Treat-to-Target for Rheumatoid Arthritis in the US: Analysis of Baseline Data From a Randomized Controlled Trial. Arthritis Care Res (Hoboken). 2018. PMID: 28834390. doi:10.1002/acr.23343
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。